Legend Biotech (LEGN) EBIT (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.66% |
| Sep 30, 2025 | -112.86% |
| Jun 30, 2025 | 17.54% |
| Mar 31, 2025 | 462.51% |
| Dec 31, 2024 | -12.71% |
| Sep 30, 2024 | -123.11% |
| Jun 30, 2024 | 50.22% |
| Mar 31, 2024 | -99.74% |
| Dec 31, 2023 | 39,857.01% |
| Sep 30, 2023 | 13.35% |
| Jun 30, 2023 | 39.82% |
| Mar 31, 2023 | 14.86% |
| Dec 31, 2022 | -19.83% |
| Sep 30, 2022 | 90.83% |
| Jun 30, 2022 | -41.92% |
| Mar 31, 2022 | 36.86% |
| Dec 31, 2021 | 10.26% |
| Sep 30, 2021 | -15.27% |
| Jun 30, 2021 | 100.72% |
| Mar 31, 2021 | -14,557.79% |
| Dec 31, 2020 | 28.48% |
| Sep 30, 2020 | 20.02% |
| Jun 30, 2020 | 6.53% |
| Mar 31, 2020 | -23.96% |
| Dec 31, 2019 | 29.93% |
| Sep 30, 2019 | 45.34% |